8-Methoxypsoralen (Oxsoralen^®)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Ampoules 0.02 mg/ml (5 ml) Available
Ampoules	0.02 mg/ml (5 ml)	Available
Näidustused: Cutaneous T-Cell Lymphoma (CTCL)

Acetylsalicylsäure (ASS)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Gastro-resistant tablets 75 mg Available
Gastro-resistant tablets	75 mg	Available
Gastro-resistant tablets 100 mg Available
Gastro-resistant tablets	100 mg	Available
Gastro-resistant tablets 160 mg Available
Gastro-resistant tablets	160 mg	Available
Tablets 75 mg Available
Tablets	75 mg	Available
Tablets 100 mg Available
Tablets	100 mg	Available
Näidustused: Antithrombotic

Brivaracetam

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 10 mg Available
Film-coated tablets	10 mg	Available
Film-coated tablets 25 mg Available
Film-coated tablets	25 mg	Available
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 75 mg Available
Film-coated tablets	75 mg	Available
Film-coated tablets 100 mg Available
Film-coated tablets	100 mg	Available
Näidustused: Epilepsy

Buprenorphine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Sublingual tablets 0.2 mg Available
Sublingual tablets	0.2 mg	Available
Sublingual tablets 0.4 mg Available
Sublingual tablets	0.4 mg	Available
Sublingual tablets 1 mg Available
Sublingual tablets	1 mg	Available
Sublingual tablets 2 mg Available
Sublingual tablets	2 mg	Available
Sublingual tablets 4 mg Available
Sublingual tablets	4 mg	Available
Sublingual tablets 6 mg Available
Sublingual tablets	6 mg	Available
Sublingual tablets 8 mg Available
Sublingual tablets	8 mg	Available
Sublingual tablets 12 mg Available
Sublingual tablets	12 mg	Available
Sublingual tablets 16 mg Available
Sublingual tablets	16 mg	Available
Näidustused: Opioid Use Disorder

Buprenorphine + Naloxone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Sublingual tablets 2 mg+0.5 mg Available
Sublingual tablets	2 mg+0.5 mg	Available
Sublingual tablets 4 mg+1 mg Available
Sublingual tablets	4 mg+1 mg	Available
Sublingual tablets 8 mg+2 mg Available
Sublingual tablets	8 mg+2 mg	Available
Sublingual tablets 12 mg+3 mg Available Q3 2025
Sublingual tablets	12 mg+3 mg	Available Q3 2025
Näidustused: Opioid Use Disorder

Candesartan + Chlortalidone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 8 mg+12.5 mg Available 2026
Tablets	8 mg+12.5 mg	Available 2026
Tablets 16 mg+12.5 mg Available 2026
Tablets	16 mg+12.5 mg	Available 2026
Tablets 32 mg+12.5 mg Available 2026
Tablets	32 mg+12.5 mg	Available 2026
Tablets 32 mg+25 mg Available 2026
Tablets	32 mg+25 mg	Available 2026
Näidustused: High Blood Pressure

Cyanocobalamin

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 1 mg Available Q4 2025
Film-coated tablets	1 mg	Available Q4 2025
Film-coated tablets 2 mg Available Q4 2025
Film-coated tablets	2 mg	Available Q4 2025
Näidustused:

Esketamine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Solution for injection or infusion 5 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	5 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 25 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	25 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 5 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	5 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion 25 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	25 mg/ml (5 ml, 10 ml, 20 ml)	Available
Näidustused: Narcotic, Severe Pain

Eslicarbazepine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 200 mg Available
Tablets	200 mg	Available
Tablets 400 mg Available
Tablets	400 mg	Available
Tablets 600 mg Available
Tablets	600 mg	Available
Tablets 800 mg Available
Tablets	800 mg	Available
Näidustused: Epilepsy

Eszopiclone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 1 mg Available
Film-coated tablets	1 mg	Available
Film-coated tablets 2 mg Available
Film-coated tablets	2 mg	Available
Film-coated tablets 3 mg Available
Film-coated tablets	3 mg	Available
Näidustused: Insomnia

Ethosuximide

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Syrup 50 mg/ml (250 ml) Available
Syrup	50 mg/ml (250 ml)	Available
Näidustused: Epilepsy

Fe²⁺ + Ascorbic Acid+ Folic Acid (Ferretab^® comp plus)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Capsules 66.7 mg+100 mg+0.8 mg Available
Capsules	66.7 mg+100 mg+0.8 mg	Available
Näidustused: Anaemia during Pregnancy

Fluoxetine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 20 mg Available
Film-coated tablets	20 mg	Available
Film-coated tablets 40 mg Available
Film-coated tablets	40 mg	Available
Näidustused: Depression

Folic Acid

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 1 mg Available
Tablets	1 mg	Available
Tablets 5 mg Available
Tablets	5 mg	Available
Näidustused: Folic Acid Deficiency

Hydromorphone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Solution for injection 2 mg/ml (1 ml) Available
Solution for injection	2 mg/ml (1 ml)	Available
Solution for injection 10 mg/ml (1 ml, 10 ml) Available
Solution for injection	10 mg/ml (1 ml, 10 ml)	Available
Solution for injection 20 mg/ml (1 ml) Available
Solution for injection	20 mg/ml (1 ml)	Available
Solution for injection 50 mg/ml (1 ml) Available
Solution for injection	50 mg/ml (1 ml)	Available
Film-coated tablets 1.3 mg Available
Film-coated tablets	1.3 mg	Available
Film-coated tablets 2.6 mg Available
Film-coated tablets	2.6 mg	Available
Prolonged-release capsules 2 mg Available 2026
Prolonged-release capsules	2 mg	Available 2026
Prolonged-release capsules 4 mg Available 2026
Prolonged-release capsules	4 mg	Available 2026
Prolonged-release capsules 8 mg Available 2026
Prolonged-release capsules	8 mg	Available 2026
Prolonged-release capsules 16 mg Available 2026
Prolonged-release capsules	16 mg	Available 2026
Prolonged-release capsules 24 mg Available 2026
Prolonged-release capsules	24 mg	Available 2026
Näidustused: Severe Pain

Ketamine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Solution for injection or infusion 10 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	10 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 50 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	50 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 10 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	10 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion 50 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	50 mg/ml (5 ml, 10 ml, 20 ml)	Available
Näidustused: Narcotic, Severe Pain

Lacosamide

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 100 mg Available
Film-coated tablets	100 mg	Available
Film-coated tablets 150 mg Available
Film-coated tablets	150 mg	Available
Film-coated tablets 200 mg Available
Film-coated tablets	200 mg	Available
Oral solution 10 mg/ml (200 ml, 500 ml) Available
Oral solution	10 mg/ml (200 ml, 500 ml)	Available
Solution for infusion 10 mg/ml (10 ml, 20 ml) Available
Solution for infusion	10 mg/ml (10 ml, 20 ml)	Available
Solution for infusion 10 mg/ml (20 ml) Available
Solution for infusion	10 mg/ml (20 ml)	Available
Näidustused: Epilepsy

Levetiracetam

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Oral solution 100 mg/ml (150 ml, 300 ml) Available
Oral solution	100 mg/ml (150 ml, 300 ml)	Available
Concentration for solution for infusion 100 mg/ml (5 ml) Available
Concentration for solution for infusion	100 mg/ml (5 ml)	Available
Näidustused: Epilepsy

Levomethadone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 2.5 mg Available
Tablets	2.5 mg	Available
Tablets 5 mg Available
Tablets	5 mg	Available
Tablets 10 mg Available
Tablets	10 mg	Available
Tablets 20 mg Available
Tablets	20 mg	Available
Tablets 30 mg Available
Tablets	30 mg	Available
Concentration for oral solution 5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml) Available
Concentration for oral solution	5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml)	Available
Näidustused: Opioid Use Disorder

Metamizole

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Solution for injection 500 mg/ml (2 ml, 5 ml) Available
Solution for injection	500 mg/ml (2 ml, 5 ml)	Available
Näidustused: Mild to Moderate Pain

Methadone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 5 mg Available
Tablets	5 mg	Available
Tablets 10 mg Available
Tablets	10 mg	Available
Tablets 20 mg Available
Tablets	20 mg	Available
Tablets 40 mg Available
Tablets	40 mg	Available
Tablets 60 mg Available
Tablets	60 mg	Available
Concentration for oral solution 10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml) Available
Concentration for oral solution	10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml)	Available
Näidustused: Opioid Use Disorder

Metoclopramide

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Oral solution 1 mg/ml (150 ml) Available
Oral solution	1 mg/ml (150 ml)	Available
Solution for injection or infusion 5 mg/ml (2 ml, 10 ml) Available
Solution for injection or infusion	5 mg/ml (2 ml, 10 ml)	Available
Näidustused: Emesis, Nausea

Morphine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Solution for injection 10 mg/ml (1 ml) Available
Solution for injection	10 mg/ml (1 ml)	Available
Solution for injection 10 mg/ml (10 ml) Available
Solution for injection	10 mg/ml (10 ml)	Available
Solution for injection 20 mg/ml (10 ml) Available
Solution for injection	20 mg/ml (10 ml)	Available
Näidustused: Severe Pain

Oxycodone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 5 mg Available
Film-coated tablets	5 mg	Available
Film-coated tablets 10 mg Available
Film-coated tablets	10 mg	Available
Film-coated tablets 20 mg Available
Film-coated tablets	20 mg	Available
Prolonged-release tablets 5 mg Available
Prolonged-release tablets	5 mg	Available
Prolonged-release tablets 10 mg Available
Prolonged-release tablets	10 mg	Available
Prolonged-release tablets 15 mg Available
Prolonged-release tablets	15 mg	Available
Prolonged-release tablets 20 mg Available
Prolonged-release tablets	20 mg	Available
Prolonged-release tablets 30 mg Available
Prolonged-release tablets	30 mg	Available
Prolonged-release tablets 40 mg Available
Prolonged-release tablets	40 mg	Available
Prolonged-release tablets 60 mg Available
Prolonged-release tablets	60 mg	Available
Prolonged-release tablets 80 mg Available
Prolonged-release tablets	80 mg	Available
Oral solution 1 mg/ml (100 ml, 250 ml, 300 ml) Available
Oral solution	1 mg/ml (100 ml, 250 ml, 300 ml)	Available
Oral solution 10 mg/ml (30 ml, 100 ml, 120 ml) Available
Oral solution	10 mg/ml (30 ml, 100 ml, 120 ml)	Available
Solution for injection or infusion 10 mg/ml (1 ml, 2 ml) Available
Solution for injection or infusion	10 mg/ml (1 ml, 2 ml)	Available
Näidustused: Severe Pain

Oxycodone + Naloxone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Prolonged-release tablets 5 mg+2.5 mg Available
Prolonged-release tablets	5 mg+2.5 mg	Available
Prolonged-release tablets 10 mg+5 mg Available
Prolonged-release tablets	10 mg+5 mg	Available
Prolonged-release tablets 20 mg+10 mg Available
Prolonged-release tablets	20 mg+10 mg	Available
Prolonged-release tablets 30 mg+15 mg Available
Prolonged-release tablets	30 mg+15 mg	Available
Prolonged-release tablets 40 mg+20 mg Available
Prolonged-release tablets	40 mg+20 mg	Available
Näidustused: Severe Pain

Perampanel

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 2 mg Available
Film-coated tablets	2 mg	Available
Film-coated tablets 4 mg Available
Film-coated tablets	4 mg	Available
Film-coated tablets 6 mg Available
Film-coated tablets	6 mg	Available
Film-coated tablets 8 mg Available
Film-coated tablets	8 mg	Available
Film-coated tablets 10 mg Available
Film-coated tablets	10 mg	Available
Film-coated tablets 12 mg Available
Film-coated tablets	12 mg	Available
Näidustused: Epilepsy

Potassium Iodide

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 65 mg Available
Tablets	65 mg	Available
Näidustused: Radiation Prophylaxis

Tapentadol

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 25 mg Available
Film-coated tablets	25 mg	Available
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 75 mg Available
Film-coated tablets	75 mg	Available
Film-coated tablets 100 mg Available
Film-coated tablets	100 mg	Available
Oral solution 20 mg/ml (100 ml, 200 ml) Available
Oral solution	20 mg/ml (100 ml, 200 ml)	Available
Prolonged-release tablets 25 mg Available
Prolonged-release tablets	25 mg	Available
Prolonged-release tablets 50 mg Available
Prolonged-release tablets	50 mg	Available
Prolonged-release tablets 100 mg Available
Prolonged-release tablets	100 mg	Available
Prolonged-release tablets 150 mg Available
Prolonged-release tablets	150 mg	Available
Prolonged-release tablets 200 mg Available
Prolonged-release tablets	200 mg	Available
Prolonged-release tablets 250 mg Available
Prolonged-release tablets	250 mg	Available
Näidustused: Severe Pain

Tizanidine

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Tablets 2 mg Available
Tablets	2 mg	Available
Tablets 4 mg Available
Tablets	4 mg	Available
Tablets 6 mg Available
Tablets	6 mg	Available
Näidustused: Muscle Spasms

Trazodone

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Oral solution 10 mg/ml (120 ml) Available
Oral solution	10 mg/ml (120 ml)	Available
Prolonged-release tablets 75 mg Available Q4 2025
Prolonged-release tablets	75 mg	Available Q4 2025
Prolonged-release tablets 150 mg Available Q4 2025
Prolonged-release tablets	150 mg	Available Q4 2025
Näidustused: Depression

Valproic Acid/Sodium Valproate

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Oral solution 300 mg/ml (100 ml) Available
Oral solution	300 mg/ml (100 ml)	Available
Näidustused: Epilepsy

Vitamin B1 (B1 =Benfotiamine)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 150 mg Available
Film-coated tablets	150 mg	Available
Film-coated tablets 300 mg Available
Film-coated tablets	300 mg	Available
Näidustused: Vitamin B1 Deficiency

Vitamin B1/B6 (B1=Benfotiamin)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 100 mg+100 mg Available
Film-coated tablets	100 mg+100 mg	Available
Näidustused: Vitamin B Deficiency

Vitamin B1/B6/B12 (B1 =Benfotiamine)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Film-coated tablets 40 mg+90 mg+0,25 mg Available
Film-coated tablets	40 mg+90 mg+0,25 mg	Available
Näidustused: Vitamin B Deficiency

Vitamin B12 (B12 =Hydroxocobalamine)

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Solution for injection 1 mg/ml (1 ml) Available
Solution for injection	1 mg/ml (1 ml)	Available
Näidustused: Vitamin B12 Deficiency

Vitamin D3

Annustamisvorm	Annustamine	Status	Välimus
Annustamisvorm / Annustamine	Välimus
Oral solution 14 400 IU/ml (12.5 ml, 30 ml) Available
Oral solution	14 400 IU/ml (12.5 ml, 30 ml)	Available
Oral solution 28 800 IU/ml (12.5 ml, 30 ml, 50 ml) Available
Oral solution	28 800 IU/ml (12.5 ml, 30 ml, 50 ml)	Available
Näidustused: Vitamin D3 Deficiency

Toimiku litsentsimine

Võta meiega ühendust.

Ettevõte

Partnerlused

Teenused

Follow us